Pet insurance can save you thousands — or leave you blindsided. Avoid these 8 common mistakes that turn “covered” claims into ...
12h
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trialsNEW YORK, Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results